Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease

Rae Ellen W Kavey, Vivek Allada, Stephen R. Daniels, Laura L. Hayman, Brian W. McCrindle, Jane W. Newburger, Rulan S. Parekh, Julia Steinberger

Research output: Contribution to journalArticle

Abstract

Title full: Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research. Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.

Original languageEnglish (US)
Pages (from-to)2710-2738
Number of pages29
JournalCirculation
Volume114
Issue number24
DOIs
StatePublished - Dec 2006
Externally publishedYes

Fingerprint

Cardiovascular Nursing
Risk Reduction Behavior
Heart Diseases
Epidemiology
Cardiovascular Diseases
Exercise
Pediatrics
Hypertension
Kidney
Research
Population
Atherosclerosis
Quality of Health Care
Risk Management
Outcome Assessment (Health Care)

Keywords

  • AHA Scientific Statements
  • Atherosclerosis
  • Cardiovascular diseases
  • Pediatrics
  • Prevention
  • Risk factors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

@article{c380676b53114a2eb93589be59af644e,
title = "Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease",
abstract = "Title full: Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research. Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.",
keywords = "AHA Scientific Statements, Atherosclerosis, Cardiovascular diseases, Pediatrics, Prevention, Risk factors",
author = "Kavey, {Rae Ellen W} and Vivek Allada and Daniels, {Stephen R.} and Hayman, {Laura L.} and McCrindle, {Brian W.} and Newburger, {Jane W.} and Parekh, {Rulan S.} and Julia Steinberger",
year = "2006",
month = "12",
doi = "10.1161/CIRCULATIONAHA.106.179568",
language = "English (US)",
volume = "114",
pages = "2710--2738",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

TY - JOUR

T1 - Cardiovascular risk reduction in high-risk pediatric patients

T2 - A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease

AU - Kavey, Rae Ellen W

AU - Allada, Vivek

AU - Daniels, Stephen R.

AU - Hayman, Laura L.

AU - McCrindle, Brian W.

AU - Newburger, Jane W.

AU - Parekh, Rulan S.

AU - Steinberger, Julia

PY - 2006/12

Y1 - 2006/12

N2 - Title full: Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research. Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.

AB - Title full: Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research. Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.

KW - AHA Scientific Statements

KW - Atherosclerosis

KW - Cardiovascular diseases

KW - Pediatrics

KW - Prevention

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=33845875445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845875445&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.106.179568

DO - 10.1161/CIRCULATIONAHA.106.179568

M3 - Article

C2 - 17130340

AN - SCOPUS:33845875445

VL - 114

SP - 2710

EP - 2738

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 24

ER -